America's three largest pharmacy chains are shutting down hundreds of locations, and the fallout is far from over.
CVS Health, Rite Aid, and Walgreens have all announced plans to close pharmacy locations across the country, citing industry pressures and shifting consumer behavior. Combined, the three retailers are on track to shutter roughly 880 stores in their most recently announced rounds — with Rite Aid's broader closure list nearing 500 overall.
A CVS spokesperson told Newsweek the company evaluates closures based on "population shifts, consumer buying patterns, store and pharmacy density, pharmacy care access, and community health needs." The company recently announced the closure of more than 270 pharmacies. CVS had already closed 900 locations between 2022 and 2024.
According to The U.S. Sun, Rite Aid announced the closures of 111 pharmacies last summer. Of those, 39 each were located in California and New York. The total list of Rite Aid closures is now nearing 500 overall.
CVS has also purchased 64 stores in Idaho, Oregon, and Washington — locations formerly operated by Rite Aid. That acquisition signals an industry consolidation pattern where stronger chains absorb the footprint of weaker competitors. It does not, however, guarantee those locations will remain open long term.
The exact closure lists for all pharmacy closures this year are not yet known. Data interpretation varies across reports, and the full scope of planned shutdowns remains unclear. What is known is that economic pressures and increased prices continue to weigh on the sector.
The issue has sparked debate among policymakers and free-market advocates alike. Some argue that overregulation and pharmacy benefit manager (PBM) conflicts are accelerating these closures, while others point to natural market corrections in an oversaturated retail pharmacy landscape.
Walgreens has been especially hard hit in recent months. Last month, the company closed a distribution center, resulting in 469 lost jobs in Illinois and another 159 in Texas. In January, Walgreens shuttered a location in Columbia, South Carolina.
In October, a Trader Joe's replaced a former Walgreens in Boston's West Roxbury neighborhood — a vivid example of how quickly retail real estate changes hands. Sycamore Partners acquired Walgreens for approximately $23.7 billion and split it into five pieces. That kind of breakup is typically a sign that a company's individual parts are worth more than the whole — not a vote of confidence in the legacy business model.
Meanwhile, a state law in Tennessee would prohibit a person or entity from owning or controlling both a pharmacy and a pharmacy benefit manager at the same time. This type of legislation targets a widely criticized practice in the industry, where vertically integrated companies can act as both the insurer and the provider. For free-market advocates, the concern isn't regulation per se — it's the distortion created when middlemen extract rents from a system consumers cannot navigate.
This is not just a pharmacy problem. Other major retailers are experiencing similar turbulence. JoAnn filed for bankruptcy twice in a year before announcing plans to close all 800 of its stores. In February, Hooters announced plans to file for Chapter 11 bankruptcy protection. Liberated Brands is closing 122 retail locations, and Forever 21 laid off 358 employees. These are not isolated events — they represent a broader pattern of brick-and-mortar contraction driven by changing consumer habits, cost pressures, and digital competition.
For consumers, the closures mean fewer options for in-person pharmacy care, particularly in rural and underserved areas. When a CVS spokesperson cites "pharmacy care access" and "community health needs" as factors in closure decisions, it raises a difficult question: who fills the gap when the last pharmacy in a neighborhood locks its doors? That question doesn't have a tidy answer yet.
For investors, the takeaway is straightforward. The retail pharmacy model, as it existed for decades, is being restructured in real time. The Walgreens acquisition by Sycamore Partners and the aggressive pruning by CVS suggest these companies see leaner operations as the only viable path forward.
The broader lesson here applies well beyond pharmacies. Industries built on physical retail density are being forced to adapt to a world where foot traffic is declining, labor costs are rising, and consumers increasingly prefer digital convenience. Whether you're watching this from a portfolio perspective or simply trying to fill a prescription, the landscape is shifting fast — and the next wave of closures is already underway.